IDO1 and cancer: In line with these observations, tumor cells overexpressing IDO were not rejected by tumor-specific T cells in a P815 mastocytoma murine model (Uyttenhove et al., 2003), further confirming the immunoregulatory role of amino acid catabolism in cancer.